Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/21591
Title: Stakeholder perspectives on pharmacist involvement in a memory clinic to review patients' medication management and assist with deprescribing.
Authors: Cross, Amanda J;Le, Vivien J;George, Johnson;Woodward, Michael C;Elliott, Rohan A
Affiliation: Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia
Medical and Cognitive Research Unit, Austin Health, Heidelberg, Victoria, Australia
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
Issue Date: 7-Aug-2019
EDate: 2019-08-07
Citation: Research in social & administrative pharmacy : RSAP 2019; online first: 7 August
Abstract: Memory clinics usually involve a team of health professionals who assess and review people with memory impairment. Memory clinic patients are typically older, have multiple comorbidities and potentially inappropriate polypharmacy. Pharmacists are not typically part of memory clinic teams. To explore stakeholder perspectives on pharmacist involvement in a memory clinic to conduct medication reviews and assist with deprescribing potentially inappropriate/unnecessary medications. Quantitative and qualitative evaluation of stakeholder perspectives within a deprescribing feasibility study. Patient/carer questionnaires were administered at 6-month follow-up. Fax-back surveys were sent to general practitioners (GPs) shortly after the pharmacist review. A focus group was conducted with memory clinic staff and semi-structured interviews with pharmacists at conclusion of the study. Focus group/interviews were transcribed and thematically analysed. Most patients/carers found the pharmacist medication review helpful (84%, 31/37) and believed it was important to have pharmacists in the memory clinic (92%, 36/39). Twenty-one (48%) GPs responded to the survey; most found the pharmacist reports useful for identifying inappropriate medication and providing deprescribing recommendations (86% and 81%, respectively), and 90% thought a pharmacist review should be part of the memory clinic service. Feedback from memory clinic staff and pharmacists was largely positive. Questions were raised by some staff about whether deprescribing fell within the clinic's scope of practice. Challenges associated with memory clinic-GP communication were highlighted. Patients, GPs and memory clinic staff were receptive to increased pharmacist involvement in the memory clinic. Stakeholder feedback will inform the development and delivery of pharmacist medication reviews and deprescribing in memory clinics.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21591
DOI: 10.1016/j.sapharm.2019.08.024
ORCID: 0000-0002-7750-9724
PubMed URL: 31405811
Type: Journal Article
Subjects: Dementia
Deprescribing
Memory clinic
Perspectives
Pharmacist
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.